Filing Details
- Accession Number:
- 0001179110-12-013848
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-10 20:01:32
- Reporting Period:
- 2012-09-06
- Filing Date:
- 2012-09-10
- Accepted Time:
- 2012-09-10 20:01:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1203343 | Dave Wentz | 3838 West Parkway Blvd Salt Lake City UT 84120 | C.e.o. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-09-06 | 27,217 | $26.06 | 511,172 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-09-06 | 27,217 | $46.75 | 483,955 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-09-07 | 16,739 | $26.06 | 500,694 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-09-07 | 16,739 | $46.52 | 483,955 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2012-09-06 | 61,918 | $0.00 | 61,918 | $26.06 |
Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2012-09-07 | 38,082 | $0.00 | 38,082 | $26.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
118,082 | 2009-07-21 | 2014-01-21 | No | 4 | M | Direct |
80,000 | 2009-07-21 | 2014-01-21 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
- Average Price. Price range was $46.65 to $46.94.
- Average Price. Price range was $46.50 to $46.67.